Roswell Park establishes Neurofibromatosis Clinic

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Roswell Park Comprehensive Cancer Center has launched a dedicated neurofibromatosis care program. 

While common among genetic conditions, neurofibromatosis is still relatively rare. It affects the nervous system as tumors that can manifest anywhere in the body. Most NF tumors are noncancerous but can cause issues like pain, scoliosis, vision and hearing loss and skin growths. 

Some nerve tumors, however, can become malignant, including those found along the spine, which can develop into a type of sarcoma known as malignant peripheral nerve sheath tumors. NF also puts individuals at an elevated risk for other types of cancers, including breast and gastrointestinal stromal tumors. 

The Neurofibromatosis Clinic provides a multidisciplinary, coordinated approach to patient care, uniting the skill and expertise of providers in many different areas:

  • Experienced diagnostic radiologists to provide prompt, accurate diagnosis,
  • Comprehensive clinical care from medical oncologists, surgical oncologists, neurosurgeons and neuro-oncologists,
  • Clinical geneticists to confirm diagnosis, plan treatment and guide testing of other family members,
  • Plastic and reconstructive surgeons to offer options for tumor removal and improved appearance,
  • Supportive care from specialists in pain management, social work and young adult health,
  • Cancer screening and surveillance for ongoing monitoring; and
  • The clinic is one of the few centers in the U.S. to provide coordinated, comprehensive care for adults with NF. Because the condition is inherited, Roswell Park offers Clinical Genetics counseling and testing, often extending services to family members in what’s known as cascade genetic testing.

“Studies have shown that there is a benefit to neurofibromatosis patients who receive care through a specialty clinic like the one we’ve established at Roswell Park,” Lindsay Lipinski, a neurosurgeon at Roswell Park, said in a statement.

YOU MAY BE INTERESTED IN

For nearly 25 years, business executive Lou Weisbach and urologist Richard J. Boxer have argued that finding the money to finance the cures for devastating diseases is not as difficult as it appears. To start finding the cures, the U.S. Department of the Treasury needs to issue some bonds—$750 billion worth. Next, you hire CEOs—one...

There is general agreement that the United States spends too much on health care, especially on pharmaceuticals.  But what we spend on drugs is not simply a function of price. If eggs double in price, people can simply cut the number of eggs they eat in half.  Simply stated, cost is the product of (price per unit times the number of units purchased). 
What did President Richard M. Nixon and Senator Edward M. Kennedy have in common? They each played a pivotal role in the passage of the National Cancer Act signed by Nixon on Dec. 23, 1971. The NCA established the National Cancer Program authorizing the initial investment in the NCI-designated Cancer Centers Program. 
When I first proposed targeting PCNA (proliferating cell nuclear antigen) as a therapeutic approach, the response I got was: “No one will ever make a drug against PCNA. It’s undruggable.” The protein lacks enzymatic activity, has a disordered region, and binds to over 200 other proteins within the cell. From a traditional drug development perspective, these characteristics made PCNA an impossible target.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login